Seres Therapeutics Inc (NASDAQ: MCRB) is -31.43% lower on its value in year-to-date trading and has touched a low of $0.54 and a high of $2.05 in the current 52-week trading range.
Winifred Gerald is a journalist specializing in financial news and analysis. With a focus on stock market trends and major shareholders, Winifred provides insights into investment opportunities and potential benefits for investors. Her articles provide a breakdown of major shareholders and highlight new developments that could impact stock performance.